Secukinumab for psoriasis in a patient with hepatitis B.

Secukinumab for psoriasis in a patient with hepatitis B.
Dermatol Online J. 2018 Sep 15;24(9):
Authors: Feaster B, Cline A, Feldman SR
Abstract
The case reported describes a 48-year-old man with congenital hepatitis B receiving secukinumab for treatment of psoriasis. Some biologic therapies have been associated with an increased risk of reactivation of hepatitis B. In the case of this patient, secukinumab has successfully managed his psoriasis without evidence of hepatitis B virus reactivation.
PMID: 30677838 [PubMed - in process]

Source: Dermatol Online J - September 15, 2018 Category: Dermatology Authors: Feaster B, Cline A, Feldman SR Tags: Dermatol Online J Source Type: research